The PI3K/mTOR Pathway Is Targeted by Rare Germline Variants in Patients with Both Melanoma and Renal Cell Carcinoma
暂无分享,去创建一个
P. Brennan | D. Bacq | A. Boland | J. Deleuze | V. Suybeng | J. McKay | B. Bressac-de Paillerets | M. Avril | M. Vallée | E. Maubec | E. Chanudet | F. Jouenne | T. M. Delhomme | Jean-Noël Hubert | J. Mckay | P. Brennan